leqembi
Your Results
-
KFF Health News: New Alzheimer’s Drug Raises Hopes — Along With Questions
August 17, 2023: The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and a precursor condition, mild cognitive impairment. Medicare has said it will pay for the therapy. Medical centers across the coun Read More >
FILTER BY:
Type
- 2019 Summer Toolkit
- 2019 Winter Toolkit
- 2020 Elections
- 2020 Regional Conferences
- 2021 Summer Toolkit
- 2021 Winter Toolkit
- 2022 Elections
- 2023 Anniversary Summer Toolkit
- 2023 OAM Toolkit
- 2023 Winter Toolkit
- 2024 Elections
- 2024 Summer Toolkit
- 2024 Winter Toolkit
- Affordable Care Act
- Affordable Care Act Page
- Alzheimer's
- Blog
- Disaster Relief
- Events
- Fact Sheets
- Fair Trade
- Medicaid
- Medicare Stories
- Member Benefit Blurbs
- Membership Meeting Stories
- Pensions
- Prescription Drug Stories
- Prescription Drugs
- Press Releases
- Reports
- Retiree Stories
- Retirement Security
- Social Security
- Syndication
- Voting Rights
